Patient Engagement Suite

  1. Reducing Macroeconomic Pressures On Clinical Trial Supply: Session 2 4/28/2023

    Join IRT industry veteran and drug supply expert Stefan Dürr for a discussion about how to reduce the impact of both traditional and emerging macroeconomic pressures on clinical trial supply.

  2. Beyond Integration: Flexible Orchestration Of IRT And eCOA Solutions 4/25/2023

    Consider how integrated response technologies and electronic clinical outcomes assessments can improve configurability, study start-up, and flexible mid-study changes.

  3. Pharma's Frozen Assets 4/18/2023

    Delve into a data-driven approach to assess the volume and value of cold chain medicines by combining IQVIA audit data with publicly available data.

  4. Using IRT Data To Automate And Optimize Clinical Supply 4/17/2023

    Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.

  5. Providing Drug Supply Support In Complex Environments Through IRT 4/5/2023

    Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.

  6. Biosample Tracking: A Consenting Dilemma 3/7/2023

    Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.

  7. Top 5 Reasons You Need IRT Expertise (Not Just Software) 7/11/2022

    Gain insight into why pharma companies generally seek IRT vendor relationships to ensure high-quality builds that meet their needs and avoid the potential pitfalls associated with RTSM.

  8. IRT And Direct-To-Patient Trials 1/12/2022

    Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.

  9. Navigating The Use Of Controlled Substances In Clinical Trials Using IRT 8/20/2021

    Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.

  10. Improving Supply Chain: Accountability, Sustainability, Optimization

    Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.